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• Limited data exist on physical activity and risk of complications to venous thromboembolism, 
VTE 
• These associations were explored in VTE patients recruited from the general population 
• Physical activity was not association with recurrence risk, but with 28% lower risk of 
mortality 
• This association was most pronounced in patients with incident deep vein thrombosis 




Background: Limited data exist on the relationship between physical activity and major complications 
after incident venous thromboembolism (VTE). 
Objectives: To investigate whether physical activity was associated with risk of recurrence and 
mortality in VTE patients recruited from the general population. 
Methods: Patients with incident VTE (n=786) derived from the Tromsø Study surveys 4-6 (1994-95, 
2001-02 and 2007-08) were included, and data on physical activity was dichotomized according to 
the activity level reported in the survey preceding the incident VTE (inactive: <1h per week, active: 
≥1h per week). Recurrent VTE and all-cause mortality were registered up to December 31, 2015. 
Hazard ratios (HRs) for recurrence and all-cause mortality were calculated using Cox regression 
models with the inactive group as reference.  
Results: There were 139 recurrences and 395 deaths during follow-up. Physical activity was not 
associated with the risk of recurrence in men (HR model 2: 1.48, 95% confidence interval (CI) 0.83-
2.65) or in women (HR model 2: 0.95, 95% CI 0.52-1.74). In contrast, physical activity was associated 
with a 28% lower risk of mortality during ten years of follow-up (HR model 3: 0.72, 95% CI 0.57-0.91). 
The inverse association was stronger in patients with a first deep vein thrombosis (DVT; HR model 2: 
0.59, 95% CI 0.44-0.79) than a pulmonary embolism (HR model 3: 0.87, 95% CI 0.61-1.26). 
Conclusion: Our results suggest that habitual physical activity prior to incident VTE does not influence 
the risk of recurrence. In contrast, active individuals were at lower risk of mortality, particularly 
following a DVT. 
 
 




Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism 
(PE), is a common disease with adverse consequences at the individual- and population level. 
Patients with VTE may suffer from short- and long-term complications, such as thrombus extension 
and embolization, physical impairment, post-thrombotic syndrome (PTS), recurrent VTE and death 
[1-4]. Hospital-related VTE is among the leading causes of disability-adjusted life years lost, and it is 
estimated that more than 500 000 VTE-related deaths occur annually in the European Union [5, 6]. 
Identification of risk factors for recurrence and mortality may improve risk stratification, secondary 
prevention, and potentially reduce the overall disease burden of VTE. 
 Although the risk of recurrence is highest during the first year after the incident event (7-
13%), the ten-year cumulative recurrence extends to 30-40% [4, 7, 8]. Characteristics of the incident 
event, patient demographics and comorbidities largely determine the risk of recurrence. Patients 
with an incident VTE provoked by a major persistent risk factor (e.g. active cancer) are at the highest 
risk, those with unprovoked VTE are at intermediate risk, and those with events provoked by a major 
transient risk factor (e.g. surgery) are at the lowest risk of recurrence [9]. Male sex and excess body 
weight are also associated with an increased risk of recurrence [10, 11]. 
 Patients with VTE have a higher risk of mortality compared to the general population, 
especially during the first year after the event [12, 13]. The one-, five, and ten-year cumulative 
mortality risks are 22-24%, 40-46% and 55%, respectively [4, 13-15]. Increasing age, smoking, 
confinement to hospital or nursing home, comorbidities and incident PE, are predictors of reduced 
survival in patients with VTE [13]. Provoked VTE is associated with a higher risk of mortality 
compared with unprovoked VTE, potentially due to higher age and more comorbidities in patients 




 There is robust evidence of an inverse association between physical activity and risk of 
several adverse health outcomes, including arterial cardiovascular disease (CVD) and premature 
mortality [16-18]. Several studies, including our recent report, have also suggested a favorable 
association between physical activity and the risk of incident VTE [19-21]. We found that 1-3 hours 
per week of light physical activity was associated with a lower VTE risk when compared to <1 hour 
per week, with limited evidence of additional benefits with increasing amounts of activity [19]. The 
role of physical activity with regards to VTE related complications is unclear. 
 To our knowledge, only one study has investigated the association between physical activity 
and risk of VTE recurrence. The Multiple Environmental and Genetic Assessment of risk factors for 
venous thrombosis (MEGA) follow-up study reported that women with a sedentary lifestyle 
(prolonged sitting) prior to the incident VTE had a 1.5-fold higher risk of recurrence, while no 
association was observed in men [22]. However, it is unknown whether regular physical activity 
influences the risk of VTE recurrence. Moreover, despite an inverse association between physical 
activity and mortality in individuals with established arterial CVD [23, 24], we are only aware of one 
study investigating this association in patients with VTE [25]. Faller et al. found that elderly VTE 
patients (≥65 years) with a low activity level had an almost two-fold increased risk of mortality during 
three years of follow-up [25]. However, whether this association applies to VTE patients in general, 
and in a long-term perspective, remains unclear. Therefore, the aims of the present study were to 
investigate the association between regular physical activity assessed prior to the incident event and 






Study population  
The source population comprised of 30 586 individuals participating in one or more of the Tromsø 
Study surveys four (1994-95), five (2001-02) and six (2007-08). The Tromsø Study is a single-center 
population-based cohort study with repeated health surveys of the inhabitants of the Tromsø 
municipality in Norway. All (Tromsø 4) or parts (Tromsø 5 and 6) of the population were invited to 
participate, and the attendance rates ranged from 66% to 79%. Detailed methodology of the Tromsø 
Study is published elsewhere [26]. Individuals who did not consent to medical research (n=181), were 
not officially registered as inhabitants of the Tromsø municipality at baseline (n=23) and with a pre-
baseline history of VTE (n=85), were excluded. The study was approved by the Regional Committee 
for Medical and Health Research Ethics, and all participants provided written informed consent prior 
to inclusion. 
 The process of VTE identification and adjudication in the Tromsø Study has been described in 
detail previously [27]. Briefly, all incident VTE events from inclusion (1994-95, 2001-02, or 2007-08) 
to the end of follow-up (December 31, 2015), were identified by searching the hospital discharge 
registry (outpatient visits and hospitalizations), the autopsy registry and the radiology procedure 
registry at the University Hospital of North Norway (UNN). UNN is the exclusive provider of all 
hospital care and relevant diagnostic radiology in the study region. Trained personnel adjudicated 
and recorded each event by thorough review of the medical records of all potential VTE cases. The 
adjudication criteria were presence of signs and symptoms of PE or DVT, combined with objective 
confirmation by radiological procedures, a recorded PE or DVT diagnosis in the patient’s journal, and 
treatment initiation unless contraindications were specified. A total of 858 incident VTE events were 
recorded during the study period. Of these, 72 were excluded due to missing information on physical 
activity in the last survey they participated in prior the VTE event, yielding 786 VTE patients eligible 
for the present study. 
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Classification of venous thromboembolism 
All incident events were classified as either DVT or PE, and concurrent disease was recorded as PE. 
The events were further classified as unprovoked, provoked or cancer-related. A cancer-related 
event was recorded if VTE occurred in a patient with overt cancer or if cancer was diagnosed within 
one year after the VTE event. Cancer-related VTE was recorded regardless of the presence of other 
provoking factors. In cancer-free individuals, provoked VTE was recorded in presence of recent 
surgery or trauma (within 8 weeks prior to the event), acute medical conditions (acute myocardial 
infarction, ischemic stroke, or major infectious disease), marked immobilization (bedrest ≥3 days, 
confined to wheelchair, or long-distance travel ≥4 h within the previous 14 days), or another 
provoking factor described by the physician in the medical record (e.g., intravascular catheters). The 
remaining VTE events were classified as unprovoked. 
 
Measurements 
Participant information was obtained by physical examinations, blood samples and self-administered 
questionnaires, and data from the most recent survey preceding the incident VTE event was used. 
Height and weight were measured with participants wearing light clothes with no shoes, and body 
mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters 
(kg/m2). Information on leisure-time physical activity, smoking habits, education, diabetes, and 
history of CVD (angina pectoris, myocardial infarction and stroke), was collected via self-administered 
questionnaires. 
 Assessment and categorization of leisure-time physical activity in the Tromsø Study has been 
described in detail previously [19]. Briefly, participants in Tromsø 4 and 5 reported their average 
weekly time spent in light (not sweating or out of breath) and hard physical activity (causing sweating 
and breathlessness) during the past year according to four categories (none, <1 hour, 1-2 hours or ≥3 
hours). Participants in Tromsø 6 reported their weekly frequency of exercise (never, less than once, 
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once, 2-3 times or approximately every day), intensity (not short-winded or sweaty, becoming short-
winded or sweaty or becoming exhausted), and average duration per session (<15 minutes, 15-29 
minutes, 30-60 minutes or >1 hour). Total weekly duration of physical activity was calculated as the 
sum of frequency and duration, and categories similar to those in Tromsø 4 and 5 were created. The 
two upper intensity-categories were considered equivalent to hard physical activity in Tromsø 4 and 
5, and the lowest intensity category equivalent to light physical activity. A common dichotomous 
activity variable was created, where the active group comprised of participants reporting physical 
activity ≥1 hour per week and the inactive group of those reporting no physical activity or <1 hour 
per week, regardless of intensity. We also constructed a five-level variable where the inactive group 
was kept unchanged and the active groups were divided in four: ‘1–3 hours per week of light 
activity’, ‘>3 hours per week of light activity’, 1–3 hours per week of hard activity’, and ‘>3 hours per 
week of hard activity’. 
 
Outcome registration 
All recurrent VTE events and deaths were recorded throughout the study period (i.e. from date of 
incident VTE up to December 31, 2015). Recurrent VTEs were identified and adjudicated using the 
same criteria as the incident events described above. Information on mortality was obtained from 
the Norwegian Population Registry. 
 
Statistical analyses 
For analyses of recurrence, person-years of follow-up were accrued from the date of the incident VTE 
to the date of recurrence, death, migration or to the end of the study period (December 31, 2015), 
whichever came first. The analytical setup was identical for the mortality analyses, except that 
recurrent VTE and migration were not included as censoring events. In cases where incident VTE and 
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death occurred on the same date (n=18), one day of follow-up was recorded for the mortality 
analyses. 
 All statistical analyses were performed with STATA version 15.1 (Stata Corp, College Station, 
TX, USA). The one-, five- and ten-year cumulative risks of recurrence and mortality according to 
physical activity status were estimated and illustrated with the Kaplan-Meier (KM) failure function (1-
KM) and the KM survivor function, respectively. The crude recurrence and mortality rates with 95% 
confidence interval (CIs) according to physical activity status were calculated and expressed as 
number of recurrences or deaths per 100 person-years. Hazard ratios (HRs) with 95% CIs were 
estimated in Cox proportional hazards regression models with the inactive group as the reference. 
The analyses were also performed across five levels of weekly physical activity to explore a potential 
dose-dependent relationship. Time on study was used as time scale in the recurrence analyses, and 
age was used as time scale in the mortality analyses. The choice of time scale (i.e. attained age or 
time on study) was based on the strength of the association between time scale and the outcome 
(e.g. the risk of recurrent VTE was regarded to be more strongly dependent on time on study than on 
age) [28]. The analyses were performed in two models for recurrence and in three models for 
mortality. For recurrence, model 1 included age and sex, while model 2 included model 1 + BMI, 
history of CVD and cancer-related VTE. Due the higher recurrence risk among men, sex-stratified 
analyses were also performed for the association between physical activity and risk of recurrence 
[11]. For mortality, model 1 include age (as time scale) and sex, model 2 included model 1 + BMI, 
education and current smoking, while model 3 included model 2 + history of CVD and cancer-related 
VTE. IRs and HRs according to physical activity status were estimated for overall recurrence and 
mortality with one, five and ten years of follow-up, and in subgroups stratified by characteristics of 
the incident events with ten years of follow-up. Due to high mortality in patients with cancer-related 
VTE, the stratified analyses were restricted to five years of follow-up for recurrence and mortality in 
this group. There were 5 participants with missing information on BMI and 12 with missing 
information on education, and these were omitted from multivariable analyses only. 
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 The risk of recurrence may be overestimated when the mortality risk is high and differs 
between exposure groups [29, 30]. In order to take competing risk by death into account, cumulative 
incidence functions and subdistribution hazard ratios (SHR) were estimated according to the method 
of Fine and Gray [29]. 
 The proportional hazards assumption was evaluated and verified on basis of Schoenfeld 
residuals and by visual inspection of the curves of the log-log survival function. Statistical interactions 
between physical activity and sex (physical activity*sex) and physical activity and age (physical 
activity*age) were tested by including the cross-product terms separately in the fully adjusted 
regression model, and no interactions were found. As the interaction between physical activity and 
age is tested through the proportional hazards assumption tests when age is used as time scale, this 
interaction-term was not relevant in the analyses of mortality. 
 The analyses were conducted under the assumption that physical activity habits prior to the 
incident VTE event are representative for the level of activity after the event. For a subgroup of 
individuals with data on physical activity in a Tromsø survey after the incident VTE (n=131), we 
describe the proportions with the same, higher and lower activity level overall, and separately for 
patients with PE and DVT. 
 
Results 
The median time between data collection at the most recent survey and the incident VTE event was 
5.5 years (interquartile range: 3.0-9.6 years). The mean age at incident VTE was 68 (±14) years, and 
51% were women. In total, 38.3% of the events were unprovoked, 34.1% provoked (non-cancer) and 
27.6% were cancer-related. Participant characteristics obtained in the Tromsø survey preceding the 
incident VTE and clinical characteristics at the time of the incident VTE according to activity status are 
shown in Table 1. Physically active participants were slightly younger at the time of the incident VTE, 
were less frequently women and less likely to have a history of CVD. The proportion of non-cancer 
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provoked events were similar between active and inactive, while there was a larger proportion of 
unprovoked VTE among the active and a larger proportion of cancer-related VTE among the inactive. 
The planned duration of anticoagulant treatment was essentially similar in active and inactive 
patients, although the proportion receiving >6 months of treatment appeared somewhat larger 
among the inactive. The distribution of provoking factors and clinical risk factors also differed 
according to activity status. The prevalence of immobilization, obesity and medical conditions (acute 
and other) was higher among the inactive, while family history of VTE was more frequent among the 
active.  
 In the subgroup of patients with data on physical activity in a Tromsø survey after the 
incident VTE event (n=131), the mean age at the incident event was 62 (±9) years, 41% were women, 
and 64% had a DVT as the first event. Of these, 75% remained in the same activity category as before 
the VTE, 18% went from active to inactive, and 7% went from inactive to active. The corresponding 
numbers were 70%, 19% and 11% in patients with PE, and 77%, 18% and 5% in patients with DVT. 
 
Recurrence 
During a median follow-up of 2.9 years, there were 139 VTE recurrences and the overall recurrence 
rate was 3.7 per 100 person-years. The cumulative recurrence risk was higher in the physically active 
individuals throughout follow-up (Fig. 1). At one year, the cumulative recurrence was 5.3% (95% CI 
2.9-9.3) in the inactive and 7.7% (95% CI 5.6-10.5) in the active. The corresponding numbers were 
15.7% (95% CI 10.8-22.7) and 19.3% (95% CI 15.6-23.7) at five years, and 25.2% (95% CI 17.0-36.3) 
and 31.3 (95% CI 25.9-37.5) at ten years. When expressed in the Cox regression model, there were no 
significant associations between physical activity and the risk of recurrent VTE (Table 2, Table S1). 
However, the risk estimates suggested a higher recurrence risk among active compared to inactive 
individuals, particularly at one year of follow-up (Table 2, HR Model 2: 1.53, 95% CI 0.77-3.05). The 
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risk estimates were unchanged when adjusting for planned duration of anticoagulant treatment 
(data not shown). 
 Sex-stratified analyses are shown in Table 3. Again, there were no significant associations 
between physical activity and recurrence risk in either men or women. However, the risk estimates 
were suggestive of a higher recurrence risk in active men after both five years (HR model 2: 1.27, 
95% CI 0.68-2.35) and ten years (HR model 2: 1.48, 95% CI 0.83-2.65). Similarly, when analyses were 
conducted across five levels of physical activity for ten-year recurrence risk, a higher weekly amount 
was associated with a progressively higher recurrence risk in men (Table S1). However, most of the 
point estimates did not reach statistical significance, and these results must be interpreted with 
caution. In women, the corresponding five- and ten-year risk estimates were close to one, but in 
opposite directions. Notably, there were very few recurrences (n=7) between five and ten years of 
follow-up in women. The power of the dose-response analyses in women were limited by few events 
in the higher activity categories, but were suggestive of a lower ten-year recurrence risk with high 
weekly activity (Table S1). 
 Analyses of the ten-year recurrence risk according to activity status stratified by 
characteristics of the incident event are shown in Table 4. Although, there were no significant 
associations between physical activity and recurrence risk, the risk estimates were suggestive of a 
higher recurrence risk in active compared to inactive individuals after provoked VTE (HR model 2: 
1.66, 95% CI 0.72-3.81) and PE (HR model 2: 1.35, 95% CI 0.64-2.82). 
 
Mortality 
There were 395 deaths during a median follow-up of 4.1 years, and the overall mortality rate was 8.8 
per 100 person-years. As shown in Fig. 2, the ten-year survival probability was lower in inactive 
compared to active individuals. The cumulative mortality at one year was 26.5% (95% CI 21.5-32.4) in 
the inactive and 20.8% (95% CI 17.6-24.5) in the active, and the mortality remained higher among the 
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inactive at both five years (48.5%, 95% CI 42.1-55.3 versus 35.7%, 95% CI 31.6-40.0) and ten years of 
follow-up (65.2%, 95% CI 57.9-72.4 versus 49.0%, 95% CI 44.4-53.9). The adjusted one-, five- and ten-
year mortality risk according to physical activity status are shown in Table 5. There was a non-
significant trend of a lower one-year mortality risk among active individuals (HR model 3: 0.81, 95% 
CI 0.57-1.17). At five and ten years of follow-up, the fully adjusted mortality risk was significantly 25% 
and 28% lower, respectively, in active compared to inactive individuals. In analyses of the ten-year 
mortality risk across five categories of physical activity, there was a threshold effect where light 
physical activity ≥1 hour per week (>the reference category) was associated with a lower risk 
compared to <1 hour per week, with no additional benefit with increasing amounts of physical 
activity (Table S2). 
 Table 6 shows the ten-year mortality risk by physical activity status stratified by 
characteristics of the incident event. Physical activity was associated with a lower risk of mortality 
after provoked (HR model 2: 0.63, 95% CI 0.40-0.97) and unprovoked VTE (HR model 2: 0.63, 95% CI 
0.40-0.99), while no association was observed for cancer-related VTE (five-year mortality risk 
reported due to high mortality rates). The ten-year cumulative mortality rates and risks according to 
physical activity status for PE and DVT are shown in Fig. 3A/Fig. 3B and Table 6. While no significant 
association was observed in patients with PE (HR model 2: 0.87, 95% CI 0.61-1.26), the ten-year 
mortality risk following DVT was 41% lower among active compared to inactive individuals (HR model 
2: 0.59, 95% CI 0.44-0.79). 
 
Competing risk by death 
The cumulative incidence of recurrence dropped when competing risk by death was taken into 
account. At one, five and ten years, the cumulative incidences were 4.6%, 10.8% and 15.8% among 
the inactive, and 6.2%, 14.4% and 20.9% among the active, respectively. Overall, the point estimates 
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In the present study, we investigated the association between habitual physical activity and the risk 
of recurrence and mortality in patients with incident VTE recruited from a general population. Our 
main findings were that (i) physical activity was associated with a lower risk of mortality, (ii) the 
inverse association appeared mainly in patients with DVT as the incident event, and (iii) there was no 
association between physical activity and the risk of VTE recurrence. 
 Despite an excess mortality risk in patients with VTE and convincing evidence of an inverse 
association between physical activity and the risk of premature mortality, this relationship has so far 
received little attention. One study conducted in elderly VTE patients reported that a low level of 
physical activity was associated with an almost two-fold higher risk of mortality during three years of 
follow-up [25]. We extend these findings showing that physical activity (≥1 hour per week) was 
associated with 19-28% lower mortality risk compared to being inactive (<1 hour per week) across 
one to ten years of follow-up in VTE patients with a wide age-range recruited from a general 
population. An inverse association between physical activity and mortality has previously been 
reported in general populations, across age groups and in relation to diseases such as cancer and 
arterial CVD, with a reported magnitude of risk reduction in the range 10-40% [16, 17, 24]. 
 The beneficial association between physical activity and mortality mainly appeared in 
patients with DVT as the incident event, while no clear association was observed in relation to PE. 
Compared to isolated DVT, PE is generally associated with a higher short-term (<1 year) mortality, 
although the difference decreases over time and the longer-term (>1 year) cumulative mortality risks 
are comparable [12, 14, 31]. The most frequently reported causes of death in patients with VTE are 
cancer, PE, other cardiovascular or respiratory diseases, and infections [14, 25, 31]. Previous studies 
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have shown that the site of the incident VTE is predictive of the site of a potential recurrence, i.e. a 
PE most often recur as a new PE and vice versa [4, 32]. Further, although the incidence of cancer is 
reported to be similar in DVT and PE [33, 34], patients with PE appear to be at a higher risk of 
myocardial infarction [35]. Potentially, such PE-specific complications may partly overwhelm a 
protective effect of physical activity on mortality, and explain the weaker association between 
physical activity and survival observed in patients with PE compared to DVT in the present study. 
 In contrast to our findings, Faller et al. reported that the inverse association between 
physical activity and mortality was largely driven by an effect in patients with PE (±DVT) [25]. There 
are several plausible explanations for the apparently diverging findings. Faller et al. assessed physical 
activity habits at the time of the incident VTE, while we used data obtained prior to the event. 
Assessing physical activity at the time of acute disease may introduce information bias, particularly in 
patients with PE, which is the more severe form of VTE. Further, their definition of PE was less 
stringent than in the present study, in that a confirmed proximal DVT together with clinical 
symptoms of PE was classified as PE without additional radiological procedures. The prevalence of PE 
was high (69%) compared to the present (42%) and other population-based studies [14, 36]. Finally, 
although we did not observe any interaction between physical activity and age in the present study, 
the age difference between the study populations (75 years vs. 68 years) may have influenced the 
findings. 
 Few studies have investigated the association between physical activity and the risk of VTE 
recurrence. Our findings indicate that habitual physical activity is not related to recurrence risk, as 
shown in both traditional Cox regression and in competing risk by death analyses. As expected, the 
SHRs were somewhat higher than the HRs, which is explained by the difference in mortality between 
active and inactive individuals. Apparently conflicting, in the MEGA follow-up study, Flinterman et al. 
found that a sedentary lifestyle (prolonged sitting) assessed at the time of incident VTE was 
associated with an increased risk of recurrence in women, while no association was observed in men 
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[22]. As it is possible for an individual to accumulative a large amount of both active and sedentary 
time (e.g. sitting hours) during a day, it has been suggested that physical activity and sedentary 
behavior should be considered as separate risk factors [37]. Accordingly, the two studies are not 
directly comparable. 
 We and others, have previously reported a beneficial association between habitual physical 
activity and the risk of incident VTE [19-21]. In recurrence research, the phenomenon “recurrence 
paradox” is often encountered, referring to the situation where a risk factor is differently related to 
first and recurrent events [38]. Because the risk of incident and recurrent VTE are compared on 
different scales (i.e. in the general population and in the VTE population), the impact of a risk factor 
(e.g. physical activity) will appear different [38]. In addition, the paradox may also occur due to index 
event bias, which arises when patients are selected based on the occurrence of an index event (e.g. 
incident VTE), and may result in underestimated or even reversed associations [39]. Accordingly, the 
lack of an association between physical activity and VTE recurrence, which contrasts previous 
findings in relation to incident VTE, may be due to aspects inherent in the research methodology. 
 In the present study, habitual physical activity was assessed prior to the incident event. In the 
subgroup of patients who returned to a survey after their incident event, 75% remained at the same 
activity level, while 25% changed behavior. A recent study in women with incident VTE reported that 
a VTE event was associated with a clinically significant decline in physical function equivalent to more 
than five years of aging, which was particularly pronounced in those with PE [3].  There are several 
consequences of VTE that may influence the post-event activity level, such as PTS, chronic pulmonary 
thromboembolic pulmonary hypertension, impaired physical function and capacity, as well as fear of 
complications in relation to exercise [2, 3, 40, 41]. Although, physical activity was associated with an 
expected lower risk of mortality in our study, non-differential misclassification of the exposure may 
be present leading to an underestimation of the true associations [42]. 
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 The main strengths of the present study include VTE patients recruited from a general 
population, wide age distribution, prospective design, and thoroughly validated and adjudicated 
outcomes. As UNN is the only provider of hospital care in the study region, a near complete VTE 
register can be anticipated. To our knowledge, this is the first study to investigate the association 
between habitual physical activity and the risk of VTE recurrence, and among the first to address the 
influence of physical activity on the risk of mortality in patients with VTE. There are some limitations 
that merit consideration. The analyses were restricted to participants who had provided information 
on their physical activity habits (92%), and the responders may differ from the non-responders. 
Further, as physical activity was assessed via self-report, there is a chance for misclassification (e.g., 
due to challenges with recall or social desirability). Likewise, changes in activity behavior following 
the incident event, may have induced misclassification. However, this is likely to be independent of 
the outcome and not a threat to the internal validity of the study. A methodological challenge in our 
study was the use of different questionnaires to assess physical activity in the different surveys of the 
Tromsø Study. However, the activity categories are shown to be meaningfully associated with 
cardiometabolic markers, which supports the validity of the variable [19]. 
In conclusion, habitual physical activity was associated with lower risk of mortality in patients 
with VTE, and DVT in particular. In contrast, the risk of VTE recurrence appeared not to be influenced 
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Tables and figures 
Table 1 Baseline and clinical characteristics of patients with incident VTE (n=786) 
 Inactive (n=251) Active (n=535) 
Baseline characteristics   
Age at incident VTE (years), mean (±SD) 70 (±14) 66 (±13) 
Sex (women), % (n) 58.2 (146) 47.7 (255) 
Body mass index (kg/m2), mean (±SD)* 27.8 (±5.1) 27.1 (±4.4) 
Education, % (n)* 18.0 (44) 23.8 (126) 
Current smoking, % (n)* 29.1 (73) 28.6 (153) 
History of cardiovascular disease, % (n)† 19.9 (50) 15.1 (81) 
Clinical presentation, % (n)   
   Deep vein thrombosis 56.2 (141) 58.3 (312) 
   Pulmonary embolism 43.8 (110) 41.7 (223) 
   Unprovoked 36.7 (92) 39.1 (209) 
   Cancer-related‡ 29.9 (75) 26.5 (142) 
   Provoked§ 33.5 (84) 34.4 (184) 
Planned treatment duration with AC, % (n)   
   0-3 months 36.7 (92) 35.5 (190) 
   3-6 months 31.5 (79) 36.5 (195) 
   6-12 months 21.5 (54) 18.5 (99) 
   > 12 months 10.4 (26) 9.5 (51) 
Provoking factors, % (n)   
   Surgery 16.4 (41) 16.5 (88) 
   Trauma 10.0 (25) 9.4 (50) 
   Acute medical condition 14.8 (37) 12.3 (66) 
   Immobilization¶ 20.7 (52) 16.5 (88) 
   Other provoking factor** 6.0 (15) 4.1 (22) 
Clinical risk factors, % (n)   
   Obesity†† 22.2 (54) 16.3 (84) 
   Family history ‡‡ 2.0 (5) 3.9 (21) 
   Other medical conditions§§ 30.7 (67) 16.9 (79) 
   Pregnancy/postpartum (of cases in women) 0.68 (1) 1.96 (5) 
   Estrogen use (of cases in women) ¶¶ 9.7 (14) 10.6 (27) 
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*Assessed at the most recent survey prior to the incident VTE event, †Angina pectoris, stroke or myocardial infarction, 
‡Active cancer or cancer diagnosed within one year after the VTE event, §Excluding cancer, ¶Bed rest ≥3 days, long-
distance travel ≥4 h within the previous 14 days, or confined to wheelchair, **Other factors specified as provoking in the 
medical record (e.g., intravascular catheters), ††Body mass index ≥30 kg/m2 at the time of incident VTE, ‡‡  Reported family 
history of VTE in first-degree relative(s) before the age of 60,  §§Other diseases within the previous year (myocardial 
infarction, ischemic stroke heart failure, inflammatory bowel disease, or myeloproliferative disorders), ¶¶Hormone 
replacement therapy or oral contraceptives. 
AC anticoagulants, SD standard deviation, VTE venous thromboembolism. 





Table 2 Incidence rates and hazard ratios with 95% confidence intervals for one-, five- and ten-year venous 
thromboembolism recurrence by physical activity status. The Tromsø Study 1994-2015. 
*Per 100 person-years, †Adjusted for age and sex, ‡Model 1+ body mass index, history of cardiovascular disease and 
cancer-related VTE.  
CI confidence interval, HR hazard ratio, IR incidence rate, SHR subdistribution hazard ratio, VTE venous thromboembolism. 
 
Table 3 Incidence rates and hazard ratios with 95% confidence intervals for five- and ten-year venous 
thromboembolism recurrence by physical activity status stratified by sex. The Tromsø Study 1994-2015. 
*Per 100 person-years, †Adjusted for age, ‡Model 1+ body mass index, history of cardiovascular disease and cancer-related 
VTE.  







HR model 1 
(95% CI)† 




One-year recurrence       
   Inactive 189 11 5.83 (3.23-10.53) 1 1 1 
   Active 431 35 8.13 (5.84-11.32) 1.52 (0.77-3.02) 1.53 (0.77-3.05) 1.65 (0.85-3.21) 
Five-year recurrence       
   Inactive 647 26 4.02 (2.73-5.90) 1 1 1 
   Active 1571 75 4.78 (3.81-5.99) 1.26 (0.80-1.97) 1.23 (0.78-1.93) 1.32 (0.84-2.08) 
Ten-year recurrence       
   Inactive 882 31 3.51 (2.47-5.00) 1 1 1 






HR model 1 
(95% CI)† 




Five-year recurrence       
Men       
   Inactive 265 13 4.91 (2.85-8.45) 1 1 1 
   Active 819 47 5.74 (4.31-7.64) 1.31 (0.71-2.44) 1.27 (0.68-2.35) 1.40 (0.76-2.57) 
Women       
   Inactive 382 13 3.40 (1.97-5.85) 1 1 1 
   Active 752 28 3.73 (2.57-5.40) 1.16 (0.60-2.26) 1.16 (0.59-2.28) 1.24 (0.62-2.48) 
Ten-year recurrence       
Men       
   Inactive 343 14 4.08 (2.42-6.89) 1 1 1 
   Active 1219 67 5.50 (4.33-6.98) 1.47 (0.82-2.63) 1.48 (0.83-2.65) 1.69 (0.96-2.99) 
Women       
   Inactive 539 17 3.15 (1.96-5.07) 1 1 1 
   Active 1135 31 2.73 (1.92-3.88) 0.96 (0.53-1.74) 0.95 (0.52-1.74) 1.03 (0.56-1.90) 
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 Table 4 Incidence rates and hazard ratios with 95% confidence intervals for ten-year venous thromboembolism 
recurrence by physical activity status stratified by characteristics of the incident event. The Tromsø Study 1994-
2015. 
*Per 100 person-years, †Adjusted for age and sex, ‡Model 1+ body mass index, §Follow-up restricted to 5 years. 







HR model 1 
(95% CI)† 




Unprovoked       
   Inactive 434 14 3.23 (1.91-5.45) 1 1 1 
   Active 1144 40 3.50 (2.56-4.77) 1.10 (0.60-2.04) 1.08 (0.58-2.02) 1.18 (0.62-2.23) 
Provoked       
   Inactive 329 7 2.13 (1.01-4.46) 1 1 1 
   Active 966 34 3.52 (2.52-4.93) 1.65 (0.72-3.77) 1.66 (0.72-3.81) 2.04 (0.91-4.54) 
Cancer-related§       
   Inactive 97 10 10.27 (5.53-19.09) 1 1 1 
   Active 190 21 11.06 (7.21-16.96) 1.02 (0.48-2.16) 0.99 (0.45-2.15)  1.01 (0.48-2.13) 
Deep vein thrombosis       
   Inactive 477 21 4.40 (2.87-6.74) 1 1 1 
   Active 1426 67 4.70 (3.70-5.97) 1.14 (0.69-1.87) 1.09 (0.66-1.80) 1.31 (0.80-2.15) 
Pulmonary embolism       
   Inactive 405 10 2.47 (1.33-4.59) 1 1 1 
   Active 928 31 3.34 (2.35-4.75) 1.30 (0.63-2.67) 1.35 (0.64-2.82) 1.40 (0.68-2.88) 
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Table 5 Mortality rates and hazard ratios with 95% confidence intervals for one-, five- and ten-year mortality in 
patients with incident venous thromboembolism by physical activity status. The Tromsø Study 1994-2015. 
*Per 100 person-years, †Adjusted for age (as time scale) and sex, ‡Model 1 + body mass index, current smoking and 
education, §Model 2 + history of cardiovascular disease and cancer-related VTE.  
CI confidence interval, HR hazard ratio, MR mortality rate, VTE venous thromboembolism. 
 
Table 6 Mortality rates and hazard ratios with 95 % confidence intervals for ten-year mortality in patients with 
incident venous thromboembolism by physical activity status stratified by characteristics of the incident event. 
The Tromsø Study 1994-2015. 
*Per 100 person-years, †Adjusted for age (as time scale) and sex, ‡Model 1 + body mass index, education and current 
smoking. §Follow-up restricted to 5 years. 






HR model 1 
(95% CI)† 
HR model 2 
(95% CI)‡ 
HR model 3 
(95% CI)§ 
One-year mortality       
   Inactive 193 66 34.16 (26.84-43.48) 1 1 1 
   Active 444 110 24.77 (20.55-29.86) 0.87 (0.62-1.20) 0.87 (0.62-1.21) 0.81 (0.57-1.17) 
Five-year  mortality       
   Inactive 695 113 16.26 (13.53-19.56) 1 1 1 
   Active 1755 181 10.31 (0.91-11.93) 0.73 (0.57-0.93) 0.71 (0.55-0.91) 0.75 (0.57-0.97) 
Ten-year  mortality       
   Inactive 983 136 13.83 (11.69-16.37)  1 1 1 







HR model 1 
(95% CI)† 
HR model 2 
(95% CI)‡ 
Unprovoked      
   Inactive 490 39 7.95 (5.81-10.88) 1 1 
   Active 1401 57 4.07 (3.14-5.27) 0.70 (0.46-1.07) 0.63 (0.40-0.99) 
Provoked      
   Inactive 354 39 11.02 (8.05-15.08) 1 1 
   Active 1101 56 5.09 (3.91-6.61) 0.58 (0.38-0.90) 0.63 (0.40-0.97) 
Cancer-related§      
   Inactive 113 54 47.75 (36.58-62.35) 1 1 
   Active 207 113 54.66 (45.46-65.73) 1.01 (0.71-1.44) 1.10 (0.74-1.62) 
Deep vein thrombosis      
   Inactive 536 88 16.39 (13.30-20.20) 1 1 
   Active 1705 129 7.56 (6.37-8.99) 0.56 (0.43-0.74) 0.59 (0.44-0.79) 
Pulmonary embolism      
   Inactive 446 48 10.76 (8.11-14.27) 1 1 
   Active 1073 100 9.32 (7.66-11.34) 0.95 (0.67-1.37) 0.87 (0.61-1.26) 
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Fig. 1 Cumulative incidence of venous thromboembolism (VTE) recurrence according to physical activity status 







Fig. 2 Survival probability after venous thromboembolism (VTE) according to physical activity status (inactive: 





Fig. 3 Survival probability after venous thromboembolism (VTE) in patients with incident deep vein thrombosis 
(Panel A) and pulmonary embolism (Panel B) according to physical activity status (inactive: <1h per week, 
active: ≥1h per week). The Tromsø Study 1994-2015. 
